Interleukin-17 and Interleukin-10 Association with Disease Progression in Schizophrenia.
Ann Neurosci
; 27(1): 24-28, 2020 Jan.
Article
en En
| MEDLINE
| ID: mdl-32982096
BACKGROUND: Alteration in cytokine levels are known to be involved in the pathogenesis of schizophrenia. OBJECTIVES: To estimate the serum levels of interleukin-17 (IL-17) and interleukin-10 (IL-10) and their association with disease progression in schizophrenia. METHODS: A total of 67 schizophrenia cases were enrolled in the present study. IL-17 and IL-10 were estimated by enzyme-linked immunosorbent assay. Positive and Negative Syndrome Scale (PANSS) was used to evaluate disease severity. RESULTS: IL-17 was positively correlated with positive symptom score (r = 0.256, p = .036), general psychopathology score (r = 0.255, p = .038) and total score (r = 0.273, p = .025) in schizophrenia. IL-17 and IL-10 were significantly increased in schizophrenia cases with PANSS more than 85 compared to those with 71-85. CONCLUSION: IL-17 and IL-10 are associated with disease severity in schizophrenia but are not good markers for predicting the disease progression.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Ann Neurosci
Año:
2020
Tipo del documento:
Article
País de afiliación:
India
Pais de publicación:
Estados Unidos